Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 434

1.

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.

Diabetes Care. 1998 May;21(5):841-8.

PMID:
9589252
2.

Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.

Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Fiehn W, Ziegler R, Wahl P, Nawroth PP.

Diabetes Care. 1997 Dec;20(12):1880-6. Erratum in: Diabetes Care 1998 Apr;21(4):678. Corrected and republished in: Diabetes Care. 1998 May;21(5):841-8.

PMID:
9405911
3.

Cardiovascular morbidity and endothelial dysfunction in chronic haemodialysis patients: is homocyst(e)ine the missing link?

Kunz K, Petitjean P, Lisri M, Chantrel F, Koehl C, Wiesel ML, Cazenave JP, Moulin B, Hannedouche TP.

Nephrol Dial Transplant. 1999 Aug;14(8):1934-42.

PMID:
10462274
4.

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy.

Tarnow L, Rossing P, Nielsen FS, Hansen BV, Dyerberg J, Parving HH.

Diabetes Care. 1996 Dec;19(12):1382-7.

PMID:
8941468
5.

Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease?

Chico A, Pérez A, Córdoba A, Arcelús R, Carreras G, de Leiva A, González-Sastre F, Blanco-Vaca F.

Diabetologia. 1998 Jun;41(6):684-93.

PMID:
9662051
6.

Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.

Langman LJ, Ray JG, Evrovski J, Yeo E, Cole DE.

Arch Intern Med. 2000 Apr 10;160(7):961-4.

PMID:
10761961
7.

Fasting and post-methionine load homocyst(e)ine values are correlated with microalbuminuria and could contribute to worsening vascular damage in non-insulin-dependent diabetes mellitus patients.

Lanfredini M, Fiorina P, Peca MG, Veronelli A, Mello A, Astorri E, Dall'Aglio P, Craveri A.

Metabolism. 1998 Aug;47(8):915-21.

PMID:
9711985
8.

[Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].

Sydow K, Böger RH.

Z Kardiol. 2001 Jan;90(1):1-11. Review. German.

PMID:
11220081
9.

Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.

Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.

Graefes Arch Clin Exp Ophthalmol. 2002 Apr;240(4):286-90. Epub 2002 Feb 21.

PMID:
11981642
10.

Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.

Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM.

Clin Nephrol. 1998 Apr;49(4):232-5.

PMID:
9582553
11.

Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.

Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.

Am J Kidney Dis. 1999 Oct;34(4):669-77.

PMID:
10516348
13.

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.

Tarnow L, Hovind P, Teerlink T, Stehouwer CD, Parving HH.

Diabetes Care. 2004 Mar;27(3):765-9.

PMID:
14988299
14.

Homocysteine levels during fasting and after methionine loading in adolescents with diabetic retinopathy and nephropathy.

Chiarelli F, Pomilio M, Mohn A, Tumini S, Vanelli M, Morgese G, Spagnoli A, Verrotti A.

J Pediatr. 2000 Sep;137(3):386-92.

PMID:
10969265
15.

The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.

Ak G, Buyukberber S, Sevinc A, Turk HM, Ates M, Sari R, Savli H, Cigli A.

J Diabetes Complications. 2001 May-Jun;15(3):150-7.

PMID:
11358684
16.

Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.

Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2930-4.

17.

Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.

Matteucci E, Rossi L, Mariani S, Fagnani F, Quilici S, Cinapri V, Giampietro O.

Nutr Metab Cardiovasc Dis. 2002 Aug;12(4):184-9.

PMID:
12514938
18.

Amadori albumin in type 1 diabetic patients: correlation with markers of endothelial function, association with diabetic nephropathy, and localization in retinal capillaries.

Schalkwijk CG, Ligtvoet N, Twaalfhoven H, Jager A, Blaauwgeers HG, Schlingemann RO, Tarnow L, Parving HH, Stehouwer CD, van Hinsbergh VW.

Diabetes. 1999 Dec;48(12):2446-53.

PMID:
10580435
19.

Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy.

Parving HH, Nielsen FS, Bang LE, Smidt UM, Svendsen TL, Chen JW, Gall MA, Rossing P.

Diabetologia. 1996 Dec;39(12):1590-7.

PMID:
8960847
20.

Plasma homocysteine and microvascular complications in type 1 diabetes.

Vaccaro O, Perna AF, Mancini FP, Iovine C, Cuomo V, Sacco M, Tufano A, Rivellese AA, Ingrosso D, Riccardi G.

Nutr Metab Cardiovasc Dis. 2000 Dec;10(6):297-304.

PMID:
11302003

Supplemental Content

Support Center